Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 226

1.

Proteomic profiling of cancer biomarkers.

Shau H, Chandler GS, Whitelegge JP, Gornbein JA, Faull KF, Chang HR.

Brief Funct Genomic Proteomic. 2003 Jul;2(2):147-58. Review.

PMID:
15239937
[PubMed - indexed for MEDLINE]
Free Article
2.

An introduction into proteomics and its clinical applications.

Ahram M.

Saudi Med J. 2007 Apr;28(4):499-507. Review.

PMID:
17457467
[PubMed - indexed for MEDLINE]
3.

Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.

Gagné JP, Gagné P, Hunter JM, Bonicalzi ME, Lemay JF, Kelly I, Le Page C, Provencher D, Mes-Masson AM, Droit A, Bourgais D, Poirier GG.

Mol Cell Biochem. 2005 Jul;275(1-2):25-55.

PMID:
16335783
[PubMed - indexed for MEDLINE]
4.

Clinical proteomics in breast cancer: a review.

Gast MC, Schellens JH, Beijnen JH.

Breast Cancer Res Treat. 2009 Jul;116(1):17-29. doi: 10.1007/s10549-008-0263-3. Epub 2008 Dec 11. Review.

PMID:
19082706
[PubMed - indexed for MEDLINE]
5.

[Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].

Solassol J, Marin P, Maudelonde T, Mangé A.

Bull Cancer. 2005 Sep;92(9):763-8. Review. French.

PMID:
16203265
[PubMed - indexed for MEDLINE]
6.

Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.

Sun S, Lee NP, Poon RT, Fan ST, He QY, Lau GK, Luk JM.

Liver Int. 2007 Oct;27(8):1021-38. Review.

PMID:
17845530
[PubMed - indexed for MEDLINE]
7.

Proteomic strategies for the characterization and the early detection of lung cancer.

Massion PP, Caprioli RM.

J Thorac Oncol. 2006 Nov;1(9):1027-39. Review.

PMID:
17409991
[PubMed - indexed for MEDLINE]
8.

Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.

Engwegen JY, Gast MC, Schellens JH, Beijnen JH.

Trends Pharmacol Sci. 2006 May;27(5):251-9. Epub 2006 Apr 4. Review.

PMID:
16600386
[PubMed - indexed for MEDLINE]
9.

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.

Celis JE, Gromov P, Cabezón T, Moreira JM, Ambartsumian N, Sandelin K, Rank F, Gromova I.

Mol Cell Proteomics. 2004 Apr;3(4):327-44. Epub 2004 Jan 30.

PMID:
14754989
[PubMed - indexed for MEDLINE]
Free Article
10.

SELDI-TOF-MS proteomics of breast cancer.

Clarke CH, Buckley JA, Fung ET.

Clin Chem Lab Med. 2005;43(12):1314-20. Review.

PMID:
16309366
[PubMed - indexed for MEDLINE]
11.

Clinical proteomics and mass spectrometry profiling for cancer detection.

Solassol J, Jacot W, Lhermitte L, Boulle N, Maudelonde T, Mangé A.

Expert Rev Proteomics. 2006 Jun;3(3):311-20. Review.

PMID:
16771703
[PubMed - indexed for MEDLINE]
12.

Proteomic patterns of tumour subsets in non-small-cell lung cancer.

Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, Roberts JR, Edgerton M, Gonzalez A, Nadaf S, Moore JH, Caprioli RM, Carbone DP.

Lancet. 2003 Aug 9;362(9382):433-9.

PMID:
12927430
[PubMed - indexed for MEDLINE]
13.

Recent advances in oncoproteomics.

Jain KK.

Curr Opin Mol Ther. 2002 Jun;4(3):203-9. Review.

PMID:
12139304
[PubMed - indexed for MEDLINE]
14.

Proteomics for the identification of new prostate cancer biomarkers.

Ornstein DK, Tyson DR.

Urol Oncol. 2006 May-Jun;24(3):231-6. Review.

PMID:
16678055
[PubMed - indexed for MEDLINE]
15.

Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.

Hodgkinson VC, Eagle GL, Drew PJ, Lind MJ, Cawkwell L.

Cancer Lett. 2010 Aug 1;294(1):13-24. doi: 10.1016/j.canlet.2010.01.036. Epub 2010 Feb 21. Review.

PMID:
20176436
[PubMed - indexed for MEDLINE]
16.

Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer.

Hirano T, Kato H.

Ann Thorac Cardiovasc Surg. 2006 Feb;12(1):4-9. Review.

PMID:
16572067
[PubMed - indexed for MEDLINE]
Free Article
17.

Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers.

Verma M, Wright GL Jr, Hanash SM, Gopal-Srivastava R, Srivastava S.

Ann N Y Acad Sci. 2001 Sep;945:103-15. Review.

PMID:
11708463
[PubMed - indexed for MEDLINE]
18.

Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.

Ou K, Yu K, Kesuma D, Hooi M, Huang N, Chen W, Lee SY, Goh XP, Tan LK, Liu J, Soon SY, Bin Abdul Rashid S, Putti TC, Jikuya H, Ichikawa T, Nishimura O, Salto-Tellez M, Tan P.

J Proteome Res. 2008 Apr;7(4):1518-28. doi: 10.1021/pr700820g. Epub 2008 Mar 5.

PMID:
18318472
[PubMed - indexed for MEDLINE]
19.

Proteomics and cancer diagnosis: the potential of mass spectrometry.

Rodland KD.

Clin Biochem. 2004 Jul;37(7):579-83. Review.

PMID:
15234239
[PubMed - indexed for MEDLINE]
20.

Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.

Seibert V, Ebert MP, Buschmann T.

Brief Funct Genomic Proteomic. 2005 May;4(1):16-26. Review.

PMID:
15975261
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk